AL healthcare facilities ordered to stop use of injectable products

10 healthcare facilities in the state have been ordered to stop using products created by the company linked to a multi-state fungal meningitis outbreak.

New England Compounding Center has voluntarily recalled all of its productspending results from the meningitis investigation. {}Although no Alabama health carefacilities received the initially recalled contaminated product, 10 health carefacilities did receive other NECC sterile injectable products.

At this time there is no evidence to indicate thatproducts other than the three initial NECC lots of methylprednisolone acetate (a steroid) are contaminated. A Health Alert Network message will be sent to allphysicians to let them know about the products recalled and what to do withpatients who present with symptoms.

The symptoms include fever,headache (new symptoms or worsening), onset of stiff neck or sensitivity tolight, or symptoms suggestive of a stroke such as slurred speech, difficultywalking, or increased dizziness or falls.

This type of meningitis is not contagious,and it cannot be spread from person to person.Additional information, including a list of statesinvolved, is available at